ATC Group: J06BB Specific immunoglobulins

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J06BB in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J06 Immune sera and immunoglobulins
3 J06B Immunoglobulins
4 J06BB Specific immunoglobulins

Group J06BB contents

Code Title
J06BB01 Anti-D (rh) immunoglobulin
J06BB02 Tetanus immunoglobulin
J06BB03 Varicella/zoster immunoglobulin
J06BB04 Hepatitis B immunoglobulin
J06BB05 Rabies immunoglobulin
J06BB06 Rubella immunoglobulin
J06BB07 Vaccinia immunoglobulin
J06BB08 Staphylococcus immunoglobulin
J06BB09 Cytomegalovirus immunoglobulin
J06BB10 Diphtheria immunoglobulin
J06BB11 Hepatitis A immunoglobulin
J06BB12 Encephalitis, tick borne immunoglobulin
J06BB13 Pertussis immunoglobulin
J06BB14 Measles immunoglobulin
J06BB15 Mumps immunoglobulin
J06BB19
J06BB30 Combinations

Active ingredients in J06BB

Active Ingredient Description
Anthrax immunoglobulin

Anthrax immuneglobulin is a human immune globulin that is used in combination with antibiotics to treat anthrax. Anthrax immunoglobulin binds to protective antigen (PA) to prevent PA mediated cellular entry of anthrax edema factor and lethal factor.

Anti-D (rh) immunoglobulin

Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known.

Cytomegalovirus immunoglobulin

Cytomegalovirus immunoglobulin is used as a CMV-specific polyclonal immunoglobulin preparation that binds to CMV surface antigens thereby neutralizing the potential of CMV from entering host cells and presenting the CMV particle for phagocytosis. Furthermore, cytomegalovirus immunoglobulin can activate CMV-reactive immune cells for long-lasting CMV-specific immune responses.

Human hepatitis B immunoglobulin

Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure.

Human antimeasles immunoglobulin
Human rabies immunoglobulin

Human rabies immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against rabies virus. Human Rabies Immunoglobulin must always be used in combination with a rabies vaccine.

Human varicela zoster immunoglobulin

Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection.

Pertussis filamentous hemagglutinin
Tetanus immunoglobulin

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.

Vaccinia immunoglobulin

Vaccinia immunoglobulin provides passive immunity for individuals with complications to vaccinia virus vaccination. The exact mechanism of action is not known.

Related product monographs

Title Information Source Document Type  
CYTOGAM Solution for infusion FDA, National Drug Code (US) MPI, US: SPL/Old
CYTOTECT CP BIOTEST Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HEPAGAM B Solution for infusion FDA, National Drug Code (US) MPI, US: SPL/PLR
HEPATECT CP Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYPERHEP B Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
HYPERRAB Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
HYPERRHO S/D FULL DOSE Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
HYPERTET Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
REGKIRONA Concentrate for solution for infusion MPI, EU: SmPC
REGKIRONA Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
RHESONATIV Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
RHOPHYLAC Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TETAGAM-P Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
VARIZIG Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
WINRHO SDF Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
ZUTECTRA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC